Similar articles for PMID: 24038106

Year	Number of Results
1940	1
1941	1
1943	1
1983	1
1985	1
1986	2
1987	1
1988	1
1989	2
1991	1
1992	3
1993	1
1994	3
1995	1
1996	1
1997	3
1998	4
2000	4
2001	1
2002	1
2003	5
2004	5
2005	3
2006	1
2007	5
2008	5
2009	9
2010	12
2011	16
2012	16
2013	19
2014	19
2015	24
2016	26
2017	15
2018	21
2019	20
2020	23
2021	37
2022	27
2023	7
2024	0

1

A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma.

Kroesen M, Nierkens S, Ansems M, Wassink M, Orentas RJ, Boon L, den Brok MH, Hoogerbrugge PM, Adema GJ. Kroesen M, et al. Int J Cancer. 2014 Mar 15;134(6):1335-45. doi: 10.1002/ijc.28463. Epub 2013 Sep 14. Int J Cancer. 2014. PMID: 24038106 Free article.

2

Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents.

Kroesen M, Brok IC, Reijnen D, van Hout-Kuijer MA, Zeelenberg IS, Den Brok MH, Hoogerbrugge PM, Adema GJ. Kroesen M, et al. Cancer Immunol Immunother. 2015 May;64(5):563-72. doi: 10.1007/s00262-015-1663-y. Epub 2015 Feb 17. Cancer Immunol Immunother. 2015. PMID: 25687736 Free PMC article.

3

Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance.

Tibbetts R, Yeo KK, Muthugounder S, Lee MH, Jung C, Porras-Corredor T, Sheard MA, Asgharzadeh S. Tibbetts R, et al. Cancer Immunol Immunother. 2022 Jan;71(1):153-164. doi: 10.1007/s00262-021-02963-y. Epub 2021 May 27. Cancer Immunol Immunother. 2022. PMID: 34043024

4

Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.

Zeng Y, Fest S, Kunert R, Katinger H, Pistoia V, Michon J, Lewis G, Ladenstein R, Lode HN. Zeng Y, et al. Mol Immunol. 2005 Jul;42(11):1311-9. doi: 10.1016/j.molimm.2004.12.018. Epub 2005 Apr 7. Mol Immunol. 2005. PMID: 15950727

5

Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2⁺ Murine Neuroblastoma.

Bates PD, Rakhmilevich AL, Cho MM, Bouchlaka MN, Rao SL, Hales JM, Orentas RJ, Fry TJ, Gilles SD, Sondel PM, Capitini CM. Bates PD, et al. Front Immunol. 2021 Aug 19;12:668307. doi: 10.3389/fimmu.2021.668307. eCollection 2021. Front Immunol. 2021. PMID: 34489927 Free PMC article.

6

GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.

Caforio M, Sorino C, Caruana I, Weber G, Camera A, Cifaldi L, De Angelis B, Del Bufalo F, Vitale A, Goffredo BM, De Vito R, Fruci D, Quintarelli C, Fanciulli M, Locatelli F, Folgiero V. Caforio M, et al. J Immunother Cancer. 2021 Mar;9(3):e001502. doi: 10.1136/jitc-2020-001502. J Immunother Cancer. 2021. PMID: 33737337 Free PMC article.

7

TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy.

McNerney KO, Karageorgos S, Ferry GM, Wolpaw AJ, Burudpakdee C, Khurana P, Toland CN, Vemu R, Vu A, Hogarty MD, Bassiri H. McNerney KO, et al. Oncoimmunology. 2022 May 24;11(1):2075204. doi: 10.1080/2162402X.2022.2075204. eCollection 2022. Oncoimmunology. 2022. PMID: 35646475 Free PMC article.

8

p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance.

Yogev O, Barker K, Sikka A, Almeida GS, Hallsworth A, Smith LM, Jamin Y, Ruddle R, Koers A, Webber HT, Raynaud FI, Popov S, Jones C, Petrie K, Robinson SP, Keun HC, Chesler L. Yogev O, et al. Cancer Res. 2016 May 15;76(10):3025-35. doi: 10.1158/0008-5472.CAN-15-1939. Epub 2016 Mar 29. Cancer Res. 2016. PMID: 27197232 Free article.

9

Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma.

Seidel D, Shibina A, Siebert N, Wels WS, Reynolds CP, Huebener N, Lode HN. Seidel D, et al. Cancer Immunol Immunother. 2015 May;64(5):621-34. doi: 10.1007/s00262-015-1669-5. Epub 2015 Feb 25. Cancer Immunol Immunother. 2015. PMID: 25711293

10

Immune characterization of pre-clinical murine models of neuroblastoma.

Webb ER, Lanati S, Wareham C, Easton A, Dunn SN, Inzhelevskaya T, Sadler FM, James S, Ashton-Key M, Cragg MS, Beers SA, Gray JC. Webb ER, et al. Sci Rep. 2020 Oct 7;10(1):16695. doi: 10.1038/s41598-020-73695-9. Sci Rep. 2020. PMID: 33028899 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

305 results

Results by year